Contraceptive vaginal rings

Seminars in Reproductive Medicine

Volumn 19, Issue 4, 2001, Pages 381-390

  Harwood, B ^a   Mishell D R , Jr ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Contraception; Sex steroid hormones; Vaginal ring

Indexed keywords

17 ACETOXY 16 METHYLENE 19 NORPROGESTERONE PLUS ETHINYLESTRADIOL; ELCOMETRINE; ESTRADIOL VALERATE PLUS NORGESTREL; ESTROGEN; ETHINYLESTRADIOL PLUS ETONOGESTREL; ETHINYLESTRADIOL PLUS NORETHISTERONE; GESTAGEN; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; SEX HORMONE; UNCLASSIFIED DRUG;

BREAST FEEDING; CONTRACEPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; FEMALE; FIRST PASS EFFECT; HUMAN; REVIEW; SIDE EFFECT; STEROID BLOOD LEVEL; SYSTEMIC CIRCULATION; UTERUS BLEEDING; VAGINA EPITHELIUM; VAGINA RING;

ADMINISTRATION, INTRAVAGINAL; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE DEVICES, FEMALE; DESOGESTREL; DRUG COMBINATIONS; ESTRADIOL; ESTROGENS; FEMALE; HUMANS; LEVONORGESTREL; NORETHINDRONE; NORPROGESTERONES; PATIENT ACCEPTANCE OF HEALTH CARE; PROGESTERONE; PROGESTINS; VINYL COMPOUNDS;

EID: 0035671838     PISSN: 15268004     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-18646     Document Type: Review

References (42)

1. The absorption of drugs and poisons through the vagina
2. Passage of steroids through silicone rubber
3. Clinical acceptability of an ethylenevinyl-acetate nonmedicated vaginal ring
4. Pharmacokinetics of 3-keto-desogestrel and ethinylestradiol released from different types of contraceptive vaginal rings
5. Pharmacokinetic and pharmacodynamic investigations with vaginal devices releasing levonorgestrel at a constant, near zero order rate
6. Levonorgestrel and estradiol release from an improved contraceptive vaginal ring
7. Contraception by means of a silastic vaginal ring impregnated with medroxyprogesterone acetate
8. Microdose intravaginal levonorgestrel contraception - A multicentre clinical trial I: Contraceptive efficacy and side effects
9. Microdose intravaginal levonorgestrel contraception - A multicentre clinical trial IV: Bleeding patterns
10. Clinical investigation of a low-dose levonorgestrel-releasing vaginal ring
11. Preliminary report of unexpected local reactions to a progestogen-releasing contraceptive vaginal ring
12. Fertility regulation in nursing women VIII: Progesterone plasma levels and contraceptive efficacy of a progesterone-releasing vaginal ring
13. The comparative trial of TCu 380A IUD and progesterone-releasing vaginal ring used by lactating women
14. Contraceptives for lactating women: A comparative trial of a progesterone-releasing vaginal ring and the copper T 380A IUD
15. Clinical performance and endocrine profiles with contraceptive vaginal rings containing a combination of estradiol and d-norgestrel
16. A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings I: Use effectiveness
17. The effect on lipids and lipoproteins of a contraceptive vaginal ring containing levonorgestrel and estradiol
18. Lipoprotein patterns in women in Santo Domingo using a levonorgestrel/estradiol contraceptive ring
19. Comparison of the metabolic effects of two hormonal contraceptive methods: An oral formulation and a vaginal ring II: Serum lipoproteins and apolipoproteins
20. Comparison of the metabolic effects of two hormonal contraceptive methods - An oral formulation and a vaginal ring I: Carbohydrate metabolism and liver function
21. Ovarian function, bleeding control and serum lipoproteins in women using contraceptive vaginal rings releasing five different progestins
22. Contraceptive steroids and coronary artery atherosclerosis in cynomolgus macaques
23. Dose-finding study of a contraceptive ring releasing norethindrone acetate/ethinyl estradiol
24. A contraceptive vaginal ring releasing norethindrone acetate and ethinyl estradiol
25. Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring
26. A comparative study of two contraceptive vaginal rings releasing norethindrone acetate and differing doses of ethinyl estradiol
27. Effect of different insertion regimens on side effects with a combination contraceptive vaginal ring
28. A contraceptive vaginal ring releasing ethinyl estradiol and the progestin ST-1435: Bleeding control, serum steroid concentrations, serum lipids and serum chemistry
29. Evaluation of four different contraceptive vaginal rings: Steroid serum levels, luteal activity, bleeding control and lipid profiles
30. Clinical performance and endocrine profiles of contraceptive vaginal rings releasing 3-keto-desogestrel and ethinylestradiol
31. Contraception with a vaginal ring releasing 3-keto desogestrel and ethinylestradiol
32. Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring
33. Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition
34. Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl estradiol
35. A detailed analysis of menstrual blood loss in women using Norplant® and Nestorone® progestogen-only contraceptive implants or vaginal rings
36. Microdose intravaginal levonorgestrel contraception - A multicentre clinical trial II: Expulsions and removals
37. A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings II: Subjective and objective measures of effects
38. Effects of contraceptive vaginal ring treatment on vaginal bacteriology and cytology
39. The effect of a contraceptive vaginal ring and oral contraceptives on the vaginal flora
40. Vaginal epithelial surface appearances in women using vaginal rings for contraception
41. Acceptability of the contraceptive vaginal ring by rural and urban population in two Latin American countries
42. Contraceptive failure rates: New estimates from the 1995 National Survey of Family Growth